Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

659
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
659
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

543
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
543
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

731
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
731
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
86
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

30.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.7K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.

American journal of preventive cardiology·2026
Same author

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Atherosclerosis·2026
Same author

Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with Dyslipidemia.

Clinical chemistry·2026
Same author

Novel MFN2 compound heterozygote genotype in a patient with multiple symmetric lipomatosis and metabolic dysfunction.

Journal of clinical lipidology·2026
Same author

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

European journal of preventive cardiology·2026
Same author

Polygenic risk scores in familial hypercholesterolemia. Do they have a role?

Current opinion in lipidology·2026

Related Experiment Video

Updated: Jun 30, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Advances in familial hypercholesterolemia.

Martine Paquette1, Alexis Baass2

  • 1Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Montreal, QC, Canada.

Advances in Clinical Chemistry
|March 21, 2024
PubMed
Summary

Familial hypercholesterolemia (FH) is a genetic disorder causing high cholesterol and early heart disease. Advances in diagnosis, risk assessment, and treatments are improving patient care and outcomes.

Keywords:
Cardiovascular diseaseFamilial hypercholesterolemiaGeneticsLDLRisk score

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.9K

Related Experiment Videos

Last Updated: Jun 30, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

29.9K

Area of Science:

  • Cardiovascular Genetics
  • Metabolic Disorders
  • Precision Medicine

Background:

  • Familial hypercholesterolemia (FH) is a prevalent genetic disorder impacting over 25 million individuals globally.
  • FH is characterized by severe hypercholesterolemia, leading to premature atherosclerotic cardiovascular disease.
  • Effective management of FH is crucial for preventing life-threatening cardiovascular events.

Purpose of the Study:

  • To review recent advancements in the diagnosis and management of Familial hypercholesterolemia.
  • To highlight the role of precision medicine in tailoring treatments for FH patients.
  • To discuss the impact of updated guidelines and novel therapeutic strategies.

Main Methods:

  • Literature review of recent studies and clinical trials in FH.
  • Analysis of data pertaining to diagnostic techniques and risk stratification tools.
  • Evaluation of current and emerging treatment modalities for hypercholesterolemia.

Main Results:

  • Significant improvements in data analysis, screening, and diagnostic accuracy for FH.
  • Enhanced cardiovascular risk stratification enabling personalized treatment approaches.
  • Beneficial impact of updated clinical guidelines and novel therapies on patient outcomes.

Conclusions:

  • Precision medicine strategies are transforming FH patient care.
  • Ongoing clinical trials are expected to provide further insights into FH management.
  • A multidisciplinary approach is essential for optimizing the long-term health of individuals with FH.